RhumbLine Advisers’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$732K Buy
52,637
+276
+0.5% +$3.79K ﹤0.01% 2370
2025
Q4
$723K Sell
52,361
-5,283
-9% -$124K ﹤0.01% 2421
2025
Q3
$1.41M Sell
57,644
-1,747
-3% -$42.5K ﹤0.01% 2076
2025
Q2
$1.37M Buy
59,391
+16,741
+39% +$441K ﹤0.01% 2092
2025
Q1
$1.15M Buy
42,650
+4,497
+12% +$170K ﹤0.01% 2101
2024
Q4
$2.04M Buy
38,153
+599
+2% +$31.7K ﹤0.01% 1865
2024
Q3
$1.71M Sell
37,554
-454
-1% -$19.8K ﹤0.01% 1994
2024
Q2
$1.59M Buy
38,008
+11,085
+41% +$520K ﹤0.01% 2004
2024
Q1
$1.01M Buy
26,923
+838
+3% +$18.3K ﹤0.01% 2242
2023
Q4
$280K Sell
26,085
-447
-2% -$3.87K ﹤0.01% 3011
2023
Q3
$267K Sell
26,532
-246
-0.9% -$2.84K ﹤0.01% 2989
2023
Q2
$318K Sell
26,778
-71
-0.3% -$949 ﹤0.01% 2971
2023
Q1
$325K Buy
26,849
+1,158
+5% +$19.3K ﹤0.01% 2586
2022
Q4
$338K Buy
25,691
+111
+0.4% +$1.63K ﹤0.01% 2630
2022
Q3
$346K Buy
25,580
+1,678
+7% +$22.4K ﹤0.01% 2669
2022
Q2
$292K Buy
23,902
+7,686
+47% +$91K ﹤0.01% 2767
2022
Q1
$233K Buy
16,216
+5,179
+47% +$84.7K ﹤0.01% 2719
2021
Q4
$218K Sell
11,037
-73
-0.7% -$1.53K ﹤0.01% 2812
2021
Q3
$240K Buy
+11,110
New +$320K ﹤0.01% 2848

Other funds holding JANX